Tuesday, November 17, 2026 Daily Briefing News Quiz
Just in
Health

Breckenridge Pharmaceutical's Urgent Recall of Propranolol Capsules: A Metal Contamination Threat

Breckenridge Pharmaceutical's Urgent Recall of Propranolol Capsules: A Metal Contamination Threat

In a move that has sent ripples through the pharmaceutical industry, Breckenridge Pharmaceuticals has announced a critical recall of a specific lot of Propranolol Hydrochloride Extended-Release Capsules. The recall, prompted by the potential presence of metal contamination, underscores the necessity of stringent quality control measures in drug manufacturing.

Understanding the Recall: Propranolol and Metal Contamination

Propranolol, a widely prescribed beta-blocker, is commonly used to manage high blood pressure, angina, and other cardiovascular conditions. The extended-release formulation of Propranolol is designed to release the medication gradually over time, providing sustained therapeutic effects. However, the current recall involves a specific lot of the 60 mg extended-release capsules, identified by Lot PK25110035 and NDC 51991-817-01. This lot has been flagged for possible metal contamination, which could potentially cause serious internal injuries if ingested.

The Scope and Immediate Actions

The recall is precise and well-defined, targeting only the 60 mg extended-release capsules in 100-count bottles. Other formulations and strengths of Propranolol, including immediate-release tablets and different extended-release strengths, are not affected by this recall. Breckenridge Pharmaceutical, based in Berkeley Heights, New Jersey, issued the recall voluntarily, emphasizing their commitment to patient safety.

Patients who have been prescribed the affected lot are advised to stop taking the medication immediately and contact their healthcare providers for further guidance. Health professionals are being urged to review patients' records, identify those who may have received the recalled lot, and take appropriate actions to ensure their safety. The affected lot was distributed nationwide, making this a widespread concern.

The Broader Context of Drug Recalls

Why does this recall matter in the broader context of drug safety? The recall of Propranolol is just the latest in a series of recent drug recalls involving blood pressure medications. Earlier this year, recalls were initiated for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets due to similar contamination issues. This string of recalls highlights the systemic challenges in maintaining the integrity of pharmaceutical products and the need for rigorous regulatory oversight.

'This recall is a stark reminder of the importance of stringent quality control measures in the pharmaceutical industry and the potential risks associated with drug contamination,'. Patients and healthcare providers must remain vigilant and proactive in responding to such alerts, ensuring that patient safety is the top priority.

The latest recall, coupled with recent recalls of other blood pressure medications, is a wake-up call for the pharmaceutical industry and regulatory bodies to intensify their efforts in monitoring and ensuring drug safety. As the public continues to rely on these medications for critical health conditions, the stakes for maintaining high standards of drug production and distribution are higher than ever.

Breckenridge Pharmaceutical's proactive recall of the affected lot of Propranolol is a testament to the company's commitment to patient safety and the broader pharmaceutical industry's ongoing efforts to mitigate contamination risks. As the healthcare community grapples with the potential impact of this recall, it also serves as a reminder of the continuous need for vigilance and innovation in drug safety protocols. The recall is a timely development, prompting a renewed focus on maintaining the highest standards of drug production and distribution. This ensures that patients continue to receive safe and effective medications without unnecessary risks. As the situation develops, patients and healthcare providers should stay informed and adhere to the latest guidelines to safeguard public health.

How does this story make you feel?

Up next · HealthGio Benitez Health Scare: The Unexpected Diagnosis